Dr Nichola Cooper is a Consultant Haematologist, trained at Cambridge University and Barts and the London School of Medicine and Dentistry. She completed her haematology training at University College Hospital and subsequently gained research experience at Cornel Medical College, New York and the Institute of Child Health, University College London. Her expertise is Immunohaematology, autoimmune diseases, thrombocytopenia and immune thrombocytopenia (ITP).
Dr Cooper has a clinical and laboratory research group focusing on understanding the molecular basis of autoimmune conditions in haematology, particularly immune thrombocytopenia (ITP), a condition leading to premature destruction of platelets. They combine genetic and genomic analysis of individuals with extreme phenotypes, CRISPR-based in vitro functional validation, and parallel ‘omic' approaches to define novel pathways regulating autoimmunity (eg Afzaku B et al Nat Immunol 2017 18:813-823).